Articles Tagged With:
-
Data Reveal Reasons for Under-enrollment of Minorities In Clinical Trials
Barriers to enrolling a diverse population of patients in clinical trials are complex and multilevel, concluded a recent study.
-
‘Very Serious Ethical Problem:’ Adverse Events Often Unpublished
Much information on adverse events in clinical trials remains unpublished — and the number of adverse events is higher in unpublished than published versions of the same study, according to a recent review.
-
Medical Assistance In Dying Now Legal In Canada: Ethicists Are Providing Education
Physician-assisted dying is legal in Canada, due to legislation passed in June 2016. Ethicists are among those providing multidisciplinary education in the hospital setting.
-
New Data on Physician-assisted Suicide in U.S.
New data on attitudes and practices of euthanasia or physician-assisted suicide from 1947 to 2016 found that physician-assisted suicide is increasingly being legalized.
-
Physician-assisted Dying: It’s ‘Perhaps the Central Question in Medical Ethics Today’
With physician-assisted dying currently legal in six states, hospitals are facing ethical questions on responding to requests and addressing conscientious objectors.
-
Pediatrics: Diet Matters
Specific diets show evidence of efficacy in the treatment of several common pediatric disorders.
-
First-ever Study of Genome Sequencing in the Common Forms of Epilepsy
In the first study with genome sequencing in the common forms of epilepsy, ultra-rare genetic mutations of known epilepsy genes were over-represented in the epilepsy population, compared to controls.
-
EEG Reactivity Testing in Comatose Patients After Severe Brain Injury
Studies assessing EEG reactivity in comatose patients after severe brain injuries are highly variable and almost never provide replicable definitions for presence or absence of EEG reactivity, even though it is used increasingly as a prognostic measure.
-
Guillain-Barré Syndrome and Hepatitis E
Hepatitis E is the most common form of viral hepatitis worldwide and often is asymptomatic. But it is commonly associated with Guillain-Barré syndrome and Guillain-Barré variants.
-
Differences in Disease Duration in LBD May Be Related to Pathologic Burden
This observational study of 807 autopsy-confirmed cases of Lewy body disease used Braak neurofibrillary tangle staging, frequency of neuritic plaques, and Lewy body staging to demonstrate that those individuals who had diffuse LBD had a shorter disease duration than those with transitional LBD localized to the limbic region.